Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Point and Lantheus’s Radioligand Drug Shows Effectiveness, but Not Enough for Wall Street
BioSpace
Mon, 12/18/23 - 10:14 pm
Point Biopharma
Lantheus Holdings
radioligands
prostate cancer
Eli Lilly
Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029
Biopharma Reporter
Mon, 12/18/23 - 11:37 am
Eli Lilly
Novo Nordisk
obesity
weight loss
Ozempic
Mounjaro
Where Will Eli Lilly Be in 5 Years?
Motley Fool
Fri, 12/15/23 - 09:42 am
Eli Lilly
Zepbound
Lilly Stock Slips as Patients Regain Weight After Stopping Zepbound
BioSpace
Mon, 12/11/23 - 10:58 pm
Eli Lilly
weight loss
Zepbound
GLP-1 agonist
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 12/8/23 - 09:56 am
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Zepbound
Eli Lilly’s latest $1.4 billion deal might come unglued
Stat
Thu, 12/7/23 - 11:15 pm
Eli Lilly
Point Biopharma
M&A
Trial finds Lilly’s Olumiant could treat type 1 diabetes
Pharmaphorum
Thu, 12/7/23 - 11:00 am
Eli Lilly
olumiant
type 1 diabetes
Eli Lilly's obesity drug now available in U.S. pharmacies
Reuters
Tue, 12/5/23 - 09:53 am
Eli Lilly
obesity
Zepbound
pharmacies
Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor
BioSpace
Mon, 12/4/23 - 09:41 am
Eli Lilly
FDA
Jaypirca
CLL
small lymphocytic leukemia
Btk inhibitors
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
Reuters
Sun, 12/3/23 - 09:29 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers
BioSpace
Wed, 11/29/23 - 11:49 am
Eli Lilly
PRISM BioLab
small molecule inhibitors
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Fierce Pharma
Tue, 11/28/23 - 11:40 pm
Teva Pharmaceutical
legal
Eli Lilly
Ajovy
patents
migraines
Eli Lilly supports Alto Neuroscience in $45m Series C round
Clinical Trials Arena
Wed, 11/22/23 - 11:30 am
Eli Lilly
Alto Neuroscience
funding
psychiatric diesase
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
Mon, 11/20/23 - 11:32 am
weightloss
Novo Nordisk
Eli Lilly
Pfizer
AstraZeneca
Wegovy
Zepbound
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Fri, 11/17/23 - 10:02 am
Lonza
drug manufacturing
obesity
Novo Nordisk
Eli Lilly
Why Eli Lilly Stock Flopped While the Market Popped Today
Motley Fool
Wed, 11/15/23 - 11:47 pm
Eli Lilly
Europe
drug manufacturing
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Wed, 11/15/23 - 12:04 pm
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
BioSpace
Mon, 11/13/23 - 11:58 am
ViaNautis Bio
Eli Lilly
genetic nanomedicine
UCB Pharma
funding
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
Pharmaphorum
Mon, 11/13/23 - 10:03 am
Eli Lilly
AHA
siRNA
lipoprotein(a)
cardiovascular disease
lepodisiran
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Sun, 11/12/23 - 09:21 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »